Catalyst Wire Dossier Catalyst Wire Dossier

ABT-450/ritonavir

paritaprevir/ritonavir · AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABT-450/ritonavir, covering 2017-02-02 to 2017-02-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection [Phase 2]

See pricing